{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.33","upperLimit":"8.72","value":"6.0"},{"groupId":"OG001","lowerLimit":"0.19","upperLimit":"5.92","value":"3.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"143"},{"groupId":"OG001","value":"133"}],"units":"Participants"}],"title":"Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.30","upperLimit":"8.75","value":"6.0"},{"groupId":"OG001","lowerLimit":"2.37","upperLimit":"8.18","value":"5.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"137"},{"groupId":"OG001","value":"124"}],"units":"Participants"}],"title":"Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.71","upperLimit":"10.41","value":"7.1"},{"groupId":"OG001","lowerLimit":"2.77","upperLimit":"8.47","value":"5.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"133"},{"groupId":"OG001","value":"122"}],"units":"Participants"}],"title":"Cycle 4 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.39","upperLimit":"8.13","value":"4.3"},{"groupId":"OG001","lowerLimit":"1.88","upperLimit":"8.26","value":"5.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"130"},{"groupId":"OG001","value":"115"}],"units":"Participants"}],"title":"Cycle 5 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.11","upperLimit":"9.85","value":"6.5"},{"groupId":"OG001","lowerLimit":"1.08","upperLimit":"7.91","value":"4.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"127"},{"groupId":"OG001","value":"105"}],"units":"Participants"}],"title":"Cycle 6 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.95","upperLimit":"9.13","value":"5.5"},{"groupId":"OG001","lowerLimit":"0.35","upperLimit":"7.55","value":"4.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"122"},{"groupId":"OG001","value":"100"}],"units":"Participants"}],"title":"Cycle 7 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.95","upperLimit":"10.37","value":"6.7"},{"groupId":"OG001","lowerLimit":"0.63","upperLimit":"7.68","value":"4.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"125"},{"groupId":"OG001","value":"94"}],"units":"Participants"}],"title":"Cycle 8 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.47","upperLimit":"10.33","value":"6.4"},{"groupId":"OG001","lowerLimit":"0.09","upperLimit":"7.69","value":"3.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"120"},{"groupId":"OG001","value":"82"}],"units":"Participants"}],"title":"Cycle 9 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.22","upperLimit":"11.20","value":"7.2"},{"groupId":"OG001","lowerLimit":"-0.02","upperLimit":"7.75","value":"3.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"116"},{"groupId":"OG001","value":"74"}],"units":"Participants"}],"title":"Cycle 10 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.27","upperLimit":"11.83","value":"8.1"},{"groupId":"OG001","lowerLimit":"-1.62","upperLimit":"5.59","value":"2.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"117"},{"groupId":"OG001","value":"73"}],"units":"Participants"}],"title":"Cycle 11 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.82","upperLimit":"11.41","value":"7.6"},{"groupId":"OG001","lowerLimit":"0.95","upperLimit":"8.59","value":"4.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"117"},{"groupId":"OG001","value":"61"}],"units":"Participants"}],"title":"Cycle 12 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.91","upperLimit":"11.11","value":"7.5"},{"groupId":"OG001","lowerLimit":"1.99","upperLimit":"9.51","value":"5.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"114"},{"groupId":"OG001","value":"56"}],"units":"Participants"}],"title":"Cycle 13 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"3.06","upperLimit":"10.32","value":"6.7"},{"groupId":"OG001","lowerLimit":"-1.33","upperLimit":"5.91","value":"2.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"title":"Cycle 14 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.33","upperLimit":"9.96","value":"6.1"},{"groupId":"OG001","lowerLimit":"-3.14","upperLimit":"6.07","value":"1.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"43"}],"units":"Participants"}],"title":"Cycle 15 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.71","upperLimit":"11.04","value":"6.9"},{"groupId":"OG001","lowerLimit":"-2.89","upperLimit":"7.71","value":"2.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"104"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"title":"Cycle 16 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.08","upperLimit":"12.46","value":"8.3"},{"groupId":"OG001","lowerLimit":"-5.05","upperLimit":"7.17","value":"1.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"93"},{"groupId":"OG001","value":"32"}],"units":"Participants"}],"title":"Cycle 17 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"4.17","upperLimit":"13.28","value":"8.7"},{"groupId":"OG001","lowerLimit":"-5.01","upperLimit":"7.56","value":"1.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"83"},{"groupId":"OG001","value":"29"}],"units":"Participants"}],"title":"Cycle 18 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.86","upperLimit":"11.70","value":"6.8"},{"groupId":"OG001","lowerLimit":"-2.79","upperLimit":"8.44","value":"2.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"78"},{"groupId":"OG001","value":"23"}],"units":"Participants"}],"title":"Cycle 19 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.83","upperLimit":"13.06","value":"7.9"},{"groupId":"OG001","lowerLimit":"-3.59","upperLimit":"10.44","value":"3.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"19"}],"units":"Participants"}],"title":"Cycle 20 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.96","upperLimit":"12.44","value":"7.2"},{"groupId":"OG001","lowerLimit":"-4.06","upperLimit":"10.64","value":"3.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"17"}],"units":"Participants"}],"title":"Cycle 21 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-0.51","upperLimit":"9.48","value":"4.5"},{"groupId":"OG001","lowerLimit":"-6.69","upperLimit":"10.54","value":"1.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"title":"Cycle 22 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-0.68","upperLimit":"11.14","value":"5.2"},{"groupId":"OG001","lowerLimit":"-10.97","upperLimit":"9.81","value":"-0.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Cycle 23 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-1.22","upperLimit":"11.09","value":"4.9"},{"groupId":"OG001","lowerLimit":"-21.43","upperLimit":"15.43","value":"-3.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"title":"Cycle 24 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-2.13","upperLimit":"10.18","value":"4.0"},{"groupId":"OG001","lowerLimit":"-11.86","upperLimit":"14.75","value":"1.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Cycle 25 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.00","upperLimit":"14.77","value":"7.9"},{"groupId":"OG001","lowerLimit":"-11.84","upperLimit":"15.84","value":"2.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Cycle 26 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-2.37","upperLimit":"11.57","value":"4.6"},{"groupId":"OG001","lowerLimit":"-12.79","upperLimit":"18.79","value":"3.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"7"}],"units":"Participants"}],"title":"Cycle 27 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-3.75","upperLimit":"15.66","value":"6.0"},{"groupId":"OG001","lowerLimit":"-13.20","upperLimit":"18.54","value":"2.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Cycle 28 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-3.78","upperLimit":"18.48","value":"7.4"},{"groupId":"OG001","lowerLimit":"-11.18","upperLimit":"27.58","value":"8.2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"title":"Cycle 29Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-5.66","upperLimit":"23.95","value":"9.1"},{"groupId":"OG001","lowerLimit":"-22.92","upperLimit":"28.42","value":"2.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Cycle 30 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-11.84","upperLimit":"27.51","value":"7.8"},{"groupId":"OG001","lowerLimit":"-190.59","upperLimit":"190.59","value":"0.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Cycle 31 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-11.65","upperLimit":"27.45","value":"7.9"},{"groupId":"OG001","lowerLimit":"-156.33","upperLimit":"161.33","value":"2.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Cycle 32 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-21.74","upperLimit":"30.49","value":"4.4"},{"groupId":"OG001","lowerLimit":"-224.86","upperLimit":"219.86","value":"-2.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Cycle 33 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-32.20","upperLimit":"31.20","value":"-0.5"},{"groupId":"OG001","value":"20.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Cycle 34 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-32.48","upperLimit":"32.48","value":"0.0"},{"groupId":"OG001","value":"20.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Cycle 35 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-315.80","upperLimit":"306.80","value":"-4.5"},{"groupId":"OG001","value":"15.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Cycle 36 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-176.33","upperLimit":"141.33","value":"-17.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 37 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Cycle 38 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-13.66","upperLimit":"6.33","value":"-3.7"},{"groupId":"OG001","lowerLimit":"-5.43","upperLimit":"2.80","value":"-1.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"82"}],"units":"Participants"}],"title":"End of Treatment"}],"denoms":[{"counts":[{"groupId":"OG000","value":"147"},{"groupId":"OG001","value":"138"}],"units":"Participants"}],"description":"The EuroQol EQ-5D-5L is a participant-completed questionnaire designed to assess health status. There are 2 components to the EuroQol EQ-5D-5L: a descriptive system in which individuals rate their level of problems (none, slight, moderate, severe, extreme/unable) in 5 areas (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and a VAS. The VAS component rates current health state on a scale from 0 (worst imaginable health state) to 100 (best imaginable health state) and higher scores indicate better health state.","dispersionType":"95% Confidence Interval","groups":[{"description":"Lorlatinib monotherapy at the recommended Phase 2 dose of 100 mg, was administered orally once daily (QD) at approximately the same time of the day on a continuous daily dosing schedule. Each treatment cycle was defined as 28 days. Treatment continued until confirmation of RECIST version 1.1 defined disease progression assessed by the blinded independent central review (unless clinical benefit was still achievable), participant refusal, participant lost to follow-up, unacceptable toxicity, death, or the study was terminated by the sponsor, whichever occurred first.","id":"OG000","title":"Lorlatinib"},{"description":"Crizotinib monotherapy at the registered dose of 250 mg, was administered orally twice daily (BID) at approximately the same time in the morning and evening (12 hours apart) on a continuous daily dosing schedule. Each treatment cycle was defined as 28 days. Treatment continued until confirmation of RECIST version 1.1 defined disease progression assessed by the blinded independent central review (unless clinical benefit was still achievable), participant refusal, participant lost to follow-up, unacceptable toxicity, death, or the study was terminated by the sponsor, whichever occurred first.","id":"OG001","title":"Crizotinib"}],"paramType":"MEAN","populationDescription":"\"Number of Participants Analyzed\" included all participants in the EQ-5D-5L PRO analysis population within each treatment group. \"Number Analyzed\" included all participants with at least a baseline and postbaseline assessment at the visit.","reportingStatus":"POSTED","timeFrame":"Baseline, Day 1 of all cycles from Cycle 2 to Cycle 38, and End of Treatment","title":"Change From Baseline in Health Status as Assessed by EuroQol 5 Dimension 5 Level (EQ-5D-5L) - Visual Analogue Scale (VAS) Across Time","type":"SECONDARY","unitOfMeasure":"Units on a scale"}